drugset / Trial / NCT02621177
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is a multi-center, randomized, double-blind Phase III clinical trial. The aim of the study is to describe the immunogenicity and safety of the trivalent cell culture-derived influenza vaccine compared to the trivalent egg-derived influenza vaccine among subjects.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-03
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Agrippal S1 | Vaccine | 0.25 ml | Intramuscular |
| Comparator | Agrippal S1 | Vaccine | 0.5 ml | Intramuscular |
| Subject | NBP607 | Vaccine | 0.25 ml | Intramuscular |
| Subject | NBP607 | Vaccine | 0.5 ml | Intramuscular |